Hardware, Robotics & IoT VC Funds

Aravaipa Ventures is a Boulder, Colorado-based venture capital firm founded in 2008 by Robert Fenwick-Smith, focusing exclusively on what the firm calls Impact Technologies — disruptive technology companies with measurable global environmental benefit. Aravaipa is notable as the only fund in the United States with a singular mandate in this category, targeting companies across transportation efficiency, building efficiency, water treatment, and smart agriculture. Fund II (AGEF2) targets $30 million and seeks 3-year returns of 5x to 10x. The firm leads rounds and deploys $250K to $1 million initially, targeting companies that already generate revenue or expect to do so rapidly and can reach profitability on less than $10 million in additional capital. With 11 investments to date, the portfolio includes Bolder Industries, Sionic Energy, Clear Comfort Water, and Lightning eMotors, which completed a public market exit. Silver Bullet was acquired. The firm co-invests alongside a Colorado-anchored syndicate that includes Factor[E], King Hill Capital, and Bohemian Companies. Aravaipa's capital-efficiency thesis is deliberate: by targeting companies that can become profitable $20 to $200 million revenue businesses without mega-rounds, the firm minimizes both dilution risk and funding dependency for founders. Robert Fenwick-Smith's environmental impact mandate extends beyond portfolio selection into active operational guidance, helping portfolio companies navigate both the technical and regulatory dimensions of bringing environmental technologies to market.

ARAX Capital Partners, founded in 2007 and based in Vienna, Austria, is a venture capital firm that focuses on early-stage investments across the life sciences and technology sectors. They are particularly invested in Austrian ventures, targeting young, innovative companies, especially those with patentable technology. ARAX is committed to fostering the growth of startups in these fields by providing significant strategic and financial support. The firm's notable investments include Calyxha Biotechnologies, EveliQure Biotechnologies, and Panoptes Pharma, showcasing their emphasis on biotech and life sciences. Additionally, they have invested in technology companies like The MoonVision and crystalsol, a renewable energy company​​. ARAX Capital Partners generally participates in funding rounds ranging from $1 million to $9 million and has made 41 investments to date. They typically lead rounds, indicating their active role in shaping the growth trajectories of their portfolio companies​​. The team at ARAX is led by experienced partners such as Christian Tiringer, Beatrix Schuberth, and Thomas Cimbal, who bring extensive expertise in venture capital and entrepreneurship to the firm​​. This leadership helps ARAX maintain a strong network and high-quality deal flow, positioning them as a key player in Austria’s venture capital landscape. For startups, ARAX Capital Partners is a valuable partner, particularly for those in the early stages of development, looking for both capital and strategic guidance to scale their innovative solutions in the biotech and technology sectors​.

Arboretum Ventures, headquartered in Ann Arbor, Michigan, is a prominent venture capital firm specializing in the healthcare sector. Founded in 2002 by Jan Garfinkle and Tim Petersen, the firm manages $1 billion across six funds. Arboretum Ventures focuses on capital-efficient investment opportunities in medical devices, life science tools, diagnostics, tech-enabled care delivery, and pharma adjacencies​. The firm has a strong commitment to investing in under-ventured geographies, particularly in the Midwest. Their portfolio includes a variety of innovative companies such as NeuMoDx, which was acquired by QIAGEN, and Fifth Eye, known for its early warning system for patient care​. Arboretum's investment strategy emphasizes supporting startups that aim to reduce healthcare costs while improving patient outcomes. They are active partners, providing strategic guidance and leveraging their extensive network to help portfolio companies succeed. The team includes managing partners Jan Garfinkle, Dr. Tom Shehab, Dan Kidle, and other key members like Paul McCreadie and Marcy Marshall. Overall, Arboretum Ventures stands out for its proactive involvement with entrepreneurs and its focus on transformative healthcare solutions that address significant industry challenges​,

Arborview Capital is a private equity firm headquartered in Chevy Chase, Maryland, founded in 2008. The firm focuses on investing in impact-driven, high-growth companies that contribute to sustainability and resource efficiency. With a deep commitment to environmental stewardship, Arborview seeks to back companies that drive positive change across industries like energy efficiency, sustainable agriculture, water conservation, and waste reduction. Their portfolio includes standout companies like Vital Farms, TemperPack, Rachio, and Copper Cow Coffee, all recognized for pushing the boundaries of sustainability and innovation. Arborview Capital typically invests between $5 million and $15 million, engaging with companies that generate at least $5 million in revenue and have a clear path to profitability. Their investment strategy is built around creating concentrated portfolios, allowing them to take a hands-on approach and form deep, strategic partnerships with management teams. They are open to leading rounds or co-investing, and often hold board positions, ensuring active involvement in scaling their companies. Geographically, Arborview primarily invests in U.S.-based companies, though they also explore opportunities in Canada and Mexico. As a B Corp certified firm, they align their financial goals with their commitment to creating lasting environmental impact, prioritizing patient capital over quick exits. Led by co-founders Joseph Lipscomb and Karl Khoury, alongside a seasoned team, Arborview prides itself on being a values-driven firm. Their approach combines deep industry expertise with a genuine passion for sustainability, making them trusted partners for entrepreneurs looking to scale impactful businesses.

Arch Venture Partners is a powerhouse in venture capital, specializing in early-stage investments in life sciences and technology. With a notable portfolio that includes industry leaders like Grail, Illumina, and Denali Therapeutics, Arch focuses on groundbreaking innovations that transform healthcare and biotech. They have a strong geographic footprint in the United States, with significant investments also in China and the UK. Their investment strategy centers on nurturing disruptive technologies with high-impact potential. Arch Venture Partners typically leads investment rounds, deploying substantial capital to accelerate growth, evidenced by their recent $2.975 billion Fund XII. The firm prioritizes deep scientific expertise and collaborates closely with founders to guide long-term strategic development. Average check sizes vary, but their robust funding capabilities mean they often make sizable commitments. Founded in 1986, Arch is driven by a team of seasoned professionals, including co-founder Robert Nelsen, who has been instrumental in the success of numerous billion-dollar companies. The firm values direct and collaborative approaches from startups, emphasizing the importance of innovative ideas backed by solid research. Overall, Arch Venture Partners stands out for its dedication to pioneering science and technology, its active role in funding and strategy, and its impressive track record of high-profile successes.

Archetype is an early-stage venture capital firm that focuses on accelerating the decentralized future, primarily backing startups in the Web3 and cryptocurrency space. Founded in 2021 and based in New York, Archetype is led by founder Ash Egan and a team of experienced professionals from the crypto, investing, and engineering worlds. The firm invests in seed-stage companies, with check sizes typically ranging from $1M to $3M. They also lead many of their funding rounds. Archetype is known for backing founders who are disrupting traditional industries by creating entirely new markets within the decentralized economy. The firm's portfolio includes standout names like Alchemy, Socket, and Mona, all of which focus on cutting-edge technologies in crypto infrastructure, blockchain development, and decentralized applications. Archetype’s investment philosophy is centered on supporting founders with deep technical expertise and a vision for decentralization. They are highly active in the U.S., with a particular focus on startups that bring innovation to financial services, infrastructure, and software development. The firm also provides strategic guidance, leveraging its team’s extensive network within the crypto ecosystem to help startups grow from concept to market-ready products. By combining their expertise in both technology and operations, Archetype positions itself as a critical partner for crypto founders looking to build and scale innovative projects in the decentralized world.

Archimed Group, founded in 2014 and headquartered in Lyon, France, is a leading private equity firm specializing in the healthcare sector. The firm manages around €8 billion in assets and is focused on investing in small to midsize companies across seven key healthcare sectors, including Biopharma, MedTech, and Healthcare IT. Archimed’s strategy involves acquiring majority stakes in companies and working closely with them to accelerate growth, drive innovation, and expand internationally. Archimed has a strong track record, with its funds consistently ranking in the top decile for performance. The firm’s latest fund, MED Platform II, closed at €3.5 billion in 2023, making it the largest healthcare-only private equity fund raised by a European-based firm. This fund is primarily focused on mid-cap companies in Europe and North America, aiming to support healthcare leaders in scaling their operations through strategic acquisitions and capacity expansions. Archimed’s commitment to impact investing is evident through its alignment with sustainable development goals and its EURÊKA Foundation, which supports healthcare-related charitable initiatives. The firm’s unique blend of financial, medical, and operational expertise positions it as a key player in the global healthcare investment landscape.

ArcTern Ventures, a Toronto-based venture capital firm with offices in San Francisco and Oslo, is dedicated to tackling climate change through investments in breakthrough technologies. Their focus areas include renewable energy, clean mobility, the circular economy, sustainable food and agriculture, and industrial decarbonization. They manage one of the world's largest dedicated climate tech funds, recently closing their oversubscribed $335 million Fund III​. ArcTern Ventures typically invests in early growth-stage companies that show significant potential for greenhouse gas emission reductions. Their strategy is to back companies with some commercial traction, aiming for those that can rapidly scale revenue and provide immediate climate impact. They often lead investment rounds, with initial checks ranging from $5 million to $10 million, and can commit up to $35 million per company, including follow-on support​. Notable investments by ArcTern Ventures include Clir Renewables, Flashfood, Hydrostor, and Terramera. These companies exemplify ArcTern’s commitment to sustainability and innovation across North America and Europe. The firm values deep research and collaboration, partnering with bold entrepreneurs to drive significant environmental impact.

Aleph VC, founded in 2013 and based in Tel Aviv, specializes in early-stage investments, primarily partnering with Israeli entrepreneurs. With $850 million under management, Aleph focuses on building meaningful companies and impactful global brands across various sectors, including fintech, digital health, cybersecurity, AI, and machine learning. Notable investments by Aleph include Lemonade, a full-stack global insurance company, and Melio, which provides digital payment tools for small businesses. Other prominent portfolio companies include Nexar, a dashcam and edge-AI platform for better driving, and Freightos, a digital freight marketplace. The firm has also seen significant exits, such as the acquisition of Raftt and the public offering of Freightos​. Aleph typically invests between $2 million and $12 million in seed and pre-seed stages, focusing on innovative companies poised for global expansion. The team, led by co-founders Michael Eisenberg and Eden Shochat, leverages their extensive network and expertise to provide strategic guidance and access to global markets, aiming to create long-term value for their portfolio companies.

Argon Ventures, based in Cambridge, Massachusetts, is a pre-seed venture fund focusing on Intelligent Industry Solutions. Founded by Robert Mason and Andrew Feinberg in 2020, Argon Ventures targets early-stage investments in Big Data & Analytics, SaaS, and Software sectors. The firm leverages its deep operational expertise to support founders in building impactful global businesses. Notable investments include companies like EnFi, Cyvl.ai, and PeakMetrics, reflecting Argon's commitment to high-tech, data-driven solutions. Argon Ventures typically leads rounds with an average investment size of around $2M, showing a preference for hands-on engagement from the earliest stages. The firm has built a strong co-investor network, collaborating with prominent investors such as Techstars and Glasswing Ventures. Argon Ventures is characterized by its proactive support in areas like team building, product strategy, and market entry. The team, including seasoned professionals like Bob Mason, brings a combination of technical insight and business acumen, helping startups navigate their growth journeys effectively. With a robust portfolio and a strategic focus on innovative tech solutions, Argon Ventures positions itself as a key player in the venture capital landscape, fostering the next generation of transformative companies.

Argonautic Ventures is a Seattle-based venture capital firm with a focus on emerging industries, including blockchain, biotech, synthetic biology, agtech, and AI. Founded in 2016, the firm takes a thesis-driven approach, identifying disruptive technologies and supporting companies across multiple stages of growth - from early MVP phases to secondary market exits. Their portfolio spans several high-impact sectors, backing companies like Molecular Assemblies, a leader in DNA synthesis technology, and Procore, a SaaS solution transforming construction project management globally. With a presence in markets across Asia and North America, Argonautic's investments reflect their goal of driving technological change and societal value. Argonautic Ventures is particularly active in supporting startups that innovate within deep learning, AI, food tech, and blockchain, with a commitment to long-term partnerships. Their strategy includes providing operational support and leveraging their global connections to help portfolio companies scale. Key team members include Viken Douzdjian and Rita Chiu, both co-founders, bringing deep expertise in operational management and investment strategy​.

Aria Ventures is a Birmingham, Michigan-based venture builder and early-stage investor founded in 2002 by Jeff Sloan. Rather than operating as a conventional VC fund, Aria provides critical development services to growing businesses in a performance-driven model: in exchange for providing resources, operational support, and strategic packaging, the firm takes equity as a long-term partner. This venture-builder orientation distinguishes Aria from funds that deploy capital without hands-on involvement. The team of three partners supports a portfolio of approximately 10 investments spanning technology, consumer, and enterprise software sectors. Aria writes checks of $100K to $1 million at pre-seed and seed stages and leads rounds, working across software, AI, hardware and robotics, and consumer technology in the United States. More recently, the firm launched a LE 50 million fund (approximately $1 million USD, with plans to grow to LE 200 million by 2029) targeting early-stage deep-tech companies in Egypt's startup ecosystem — specifically artificial intelligence, robotics, biotechnology, nanotechnology, and the Internet of Things. Aria Ventures' expansion into Egypt reflects a conviction that frontier technology talent exists well outside the established venture hubs and that hands-on operational support — not just capital — is the scarce resource that enables early-stage deep-tech companies to commercialize. The firm's dual presence in Michigan and the MENA region gives it an unusual geographic footprint for a fund of its size.

Arix Bioscience is a global venture capital firm based in London, specializing in biotechnology investments. Founded in 2016, Arix focuses on backing early-stage companies that are developing breakthrough treatments and technologies in the life sciences sector. Their investment strategy targets ventures from late pre-clinical to clinical stages, emphasizing a diversified portfolio to mitigate risks inherent in biotech investments​. The firm has built a robust portfolio that includes companies like Autolus, a developer of CAR-T cell therapies for cancer, and Disc Medicine, which focuses on treatments for hematologic diseases. Arix has also been involved in significant financing rounds, such as the $50 million Series B for Evommune and Ensoma, highlighting their role in advancing innovative biotech startups. Arix operates a permanent capital model, allowing it to support its portfolio companies through market fluctuations without being bound by strict exit timelines. This approach enables them to provide sustained support to their investments, which is critical in the high-risk, high-reward biotech sector.

Arkitekt Ventures is a New York-based venture capital firm focused on advancing human health through early-stage investments. Their portfolio emphasizes innovative healthcare solutions, including digital health platforms, biotech, and frontier technologies like neurotech, AI, and bioengineering. Notable recent investments include Sollis Health, Nanite, and Mural Health, with check sizes ranging from $3M to $15M. Arkitekt primarily invests in the U.S. but has also backed companies in the UK, maintaining a sector focus in healthtech, medical devices, and life sciences. Their strategy centers on pre-seed to Series A stages, preferring startups with groundbreaking approaches to healthcare delivery and precision medicine. They rarely lead rounds but frequently co-invest with prominent partners like Bessemer Venture Partners and Torch Capital. Led by managing director Enke Bashllari and partner Pavan Choksi, Arkitekt Ventures values long-term partnerships and tends to back visionary founders who are leveraging cutting-edge science. Their team prefers a data-driven, relationship-building approach, and startups seeking funding should ideally present transformative technologies with strong early traction.

Armilar Venture Partners is a leading venture capital firm based in Lisbon, Portugal, with a strong international presence. Since its founding in 2000, Armilar has focused on early-stage technology-based companies, particularly in sectors where data, digitization, and connectivity are central. Notable investments include OutSystems, Feedzai, and Vawlt, showcasing their commitment to companies driving digital transformation. Armilar specializes in deep-tech investments, supporting startups that leverage cutting-edge technology to address significant societal challenges. They have a hands-on approach, providing not only capital but also strategic guidance to help their portfolio companies scale effectively. Their investment strategy includes focusing on companies with strong intellectual property and significant market potential, often leading funding rounds to ensure their startups have the resources needed for success. Geographically, while Armilar has a strong focus on Portugal, they are open to investing globally, demonstrating flexibility in finding and supporting the best opportunities regardless of location. Their investment strategy is characterized by patience and long-term support, often leading funding rounds and staying engaged through critical growth phases. The firm has a notable team, including Joaquim Rodrigues, the founder, and managing partners like Nuno Leite and Pedro Santos. These leaders bring extensive experience and a deep understanding of both technology and market dynamics, ensuring they can provide valuable support to their portfolio companies.

Arnold Venture Group is a Pacific Northwest-based venture capital firm that focuses on innovative companies across sectors like information technology, software, infrastructure, and business intelligence. Established in 2018, the firm invests in early to growth-stage companies, with check sizes ranging from $250K to $5M. Arnold Venture Group places a strong emphasis on companies with social impact, making strategic investments in the U.S. market. The firm has a diverse portfolio that includes sectors like media, healthcare, and food/agriculture. Notable investments include Videon Labs, AdaptX, and Picnic, demonstrating their wide-reaching impact across different industries. Arnold Venture Group typically co-invests alongside other well-known venture firms such as Voyager Capital and Vulcan, further enhancing its reach and network. Led by a small, experienced team, including partners Cole Younger and Robert Arnold, the firm supports its portfolio companies by leveraging deep industry knowledge and strategic connections. With its focus on scaling impactful companies, Arnold Venture Group continues to be a strong player in the venture capital ecosystem.

The Advanced Research Projects Agency-Energy (ARPA-E) is a U.S. government agency that promotes the development of innovative energy technologies that are not yet ready for private-sector investment. ARPA-E funds projects aimed at transforming the ways we generate, store, and use energy, with the goal of enhancing U.S. economic prosperity, national security, and environmental sustainability. ARPA-E's mission includes supporting high-impact energy research with small, targeted investments that can catalyze significant advancements in energy technology. They issue periodic Funding Opportunity Announcements (FOAs), including OPEN FOAs, to identify and support innovative projects across a wide range of energy-related fields. These fields include electricity generation, storage, distribution, energy efficiency, and transportation. One of their initiatives, the SPARKS program, provides rapid support for early-stage research to explore new and disruptive energy concepts. This program aims to identify innovative ideas that have the potential to make a significant impact on ARPA-E's mission areas. ARPA-E also offers a streamlined awards process and active program management to ensure that funded projects can advance quickly and effectively. They empower energy researchers with funding, technical assistance, and market readiness support.

Array Ventures, founded in 2015 and based in San Francisco, focuses on early-stage investments in enterprise technology startups. The firm is led by Shruti Gandhi, who leverages her extensive background in software engineering and venture capital to support innovative companies. Array Ventures primarily invests in enterprise SaaS, data, AI, security, infrastructure, and cloud technologies. They typically invest between $250,000 to $2 million in pre-seed and seed rounds, aiming for 8-15% ownership in their portfolio companies. Notable investments by Array Ventures include Simility (acquired by PayPal), CasaOne, Blumira, MadStreet Den, Modal, and Uniform.dev. The firm has a strategic focus on founders with strong technical backgrounds who are leaving lucrative corporate jobs to tackle significant problems. They provide robust support to help these startups grow from initial stages to achieving significant ARR milestones. Array Ventures also has a global investment approach, backing companies that address worldwide markets, including notable investments in Indian and Israeli startups.

Arrington XRP Capital is a dynamic cryptocurrency hedge fund, known for its strategic investments in blockchain technology and digital assets. Founded by Michael Arrington, the former TechCrunch founder, the fund has a significant footprint in the crypto space, backing notable startups such as Nexo, ThunderCore, and Algofi. Their investment portfolio spans various sectors including decentralized finance (DeFi), gaming, and blockchain infrastructure, with companies like Palm Tree Crew, Sipher, and Tinyman showcasing their diverse interests. Arrington XRP Capital primarily focuses on early-stage ventures and Initial Coin Offerings (ICOs), favoring innovative blockchain projects that demonstrate strong potential for growth. The fund operates globally, with no strict geographic limitations, allowing it to capture opportunities across different markets. The investment strategy is rigorous and thoughtful, typically participating in funding rounds with multiple investors to diversify risk. They prefer projects with robust technical foundations and visionary teams, aiming to support the long-term development of the blockchain ecosystem. The fund's typical check size varies, but they are known for leading rounds and providing substantial backing to promising startups​.

Artesian Investments, founded in 2004 by Jeremy Colless, Matthew Clunies-Ross, and John McCartney, is a global alternative investment management firm specializing in venture capital, public and private debt, and impact investment strategies. Based in Sydney, the firm has expanded its reach with offices in Melbourne, Adelaide, Shanghai, Jakarta, Singapore, London, and New York​​. Artesian's notable investments include Instaclustr, PouchNATION, and Regrow Ag. They are particularly active in the Asia-Pacific region, managing over $1.22 billion in assets and boasting more than 600 startup investments​ (Artesian)​. Their investment strategy focuses on early-stage ventures across various sectors, including technology, agrifood, medtech, and AI. Artesian also offers a unique "Venture Capital as a Service" (VCaaS) platform, providing customized investment solutions to corporations, government, and family offices​. The firm places a strong emphasis on ESG (Environmental, Social, and Governance) criteria and impact investing, aiming to deliver sustainable returns while addressing critical global challenges. Artesian is a certified B Corp, underscoring their commitment to positive social and environmental impact. Key team members include Jeremy Colless (CEO), Matthew Clunies-Ross (CIO), and Luke Fay (Partner, Australian Venture Capital). Their diversified team spans multiple continents, bringing extensive expertise and a global perspective to their investment activities

Artiman Ventures, founded in 2001, is a venture capital firm based in Silicon Valley with an additional office in Bangalore. The firm specializes in early-stage investments and adopts a "white space" investment strategy, focusing on sectors with little to no existing competition, thereby seeking to create or disrupt multi-billion dollar markets. Artiman is sector-agnostic and invests across a diverse range of industries including technology, medtech, and communications. Notable investments in Artiman's portfolio include companies like Virsec, which focuses on application security, and Visby Medical, which is revolutionizing disease diagnostics. Other significant investments include ApplyBoard, an AI-enabled marketplace for international students, and CellMax Life, a precision cancer blood-testing company. Geographically, Artiman primarily invests in companies based in the U.S. and India, leveraging its cross-border presence to help startups scale globally. Their investment strategy involves being the first institutional capital, often at the concept phase, and working closely with entrepreneurs to drive strategy, market definition, and execution​. The leadership team at Artiman includes experienced partners like Yatin Mundkur, Amit Shah, and Ajit Singh, who bring deep expertise in technology and life sciences investments. Founder Eric Benhamou, known for his tenure as CEO of 3Com and Palm, leads the team with a strong background in growing and managing tech companies.

Asahi Kasei Ventures — formally Asahi Kasei Corporate Venture Capital — is the CVC arm of Asahi Kasei Corporation, a diversified Japanese conglomerate with revenues exceeding $20 billion across its Materials, Homes, and Health Care divisions. Established in 2008 in Tokyo and operating from Silicon Valley since 2011, with additional offices in Menlo Park and Boston, the fund invests in innovative startups strategically aligned with Asahi Kasei's long-term business development. General Manager Takashi Morishita has guided the fund since inception, personally involved in investments in 30-plus startups. The firm has invested in 53-plus companies across the United States, Europe, China, and Japan, averaging two new investments annually. Checks range from $1 million to $10 million at seed through Series B stages. Focus areas include healthcare and digital health, advanced materials, IoT, clean technology, energy storage, hydrogen, and biopharmaceuticals. The most recent investment was in Glycomine at Series C in April 2025. The fund's Care for Earth investment framework extends the mandate to environmental startups in sustainability and carbon neutrality. Portfolio companies gain access to Asahi Kasei's extensive research capabilities, manufacturing infrastructure, and global commercial network — advantages that have resulted in multiple strategic collaborations and two acquisitions for the parent company. The fund's long-term orientation and corporate backing allow it to support companies through extended development cycles that financial-only investors may not sustain.

Ascend Venture Capital, based in Seattle and led by Kirby Winfield, focuses on pre-seed investments in AI infrastructure and "SaaS 3.0" applications. Their primary mission is to back startups that leverage artificial intelligence to disrupt traditional B2B software markets. They typically write checks ranging from $250K to $750K and prefer to invest in local Seattle-based founders. The firm has a strong emphasis on long-term support, guiding founders from idea inception to Series A and beyond. Ascend has an impressive track record of exits, including notable companies like Attunely and Makara. They are particularly interested in mission-critical, data-centric startups, and are recognized for their diverse investment approach-63% of their portfolio is composed of minority-led teams. The team at Ascend also prides itself on fostering deep relationships with portfolio founders, providing not only capital but also connections to customers and Silicon Valley investors. Ascend’s ethos focuses on avoiding crowded markets, instead seeking opportunities in emerging verticals and industries.

Ascend Venture Capital, founded in 2015 and headquartered in St. Louis, Missouri, is a beacon of innovation in the Midwest venture capital landscape. The fund primarily invests in early-stage startups across a variety of sectors including AI/ML, SaaS, and commercial products. Notable portfolio companies include Vouched, WhyLabs, and Yoodli, showcasing their commitment to cutting-edge technology and impactful solutions. With a strategic focus on the Midwest, Ascend aims to demonstrate that top-tier venture capital doesn't need to be confined to the coasts. Their investment strategy involves rigorous due diligence and a methodical approach akin to clinical trials. Ascend's first fund aimed to validate their investment thesis, while subsequent funds have stress-tested their systems and expanded their team. The average check size is around $2 million, and they participate in approximately six investment rounds annually. Ascend often uses special purpose vehicles (SPVs) to amplify investments in high-potential portfolio companies, particularly during critical Series A and B stages. The team is led by Dan Conner, the founding general partner, and Yinka Faleti, a key partner, both based in St. Louis. They emphasize human-centered values and transparency, fostering strong, genuine relationships with portfolio companies and investors alike. Ascend’s disciplined approach and focus on integrity and inclusivity have positioned them as a leading venture capital firm in the Midwest​.

Ascension Ventures is a strategic healthcare-focused venture capital firm based in St. Louis, Missouri. Launched in 2001 by Ascension, it manages over $1 billion in assets across five funds. The firm strategically invests in early to late-stage companies within healthcare services, health technology, and medical devices. Its unique approach connects more than 450 healthcare providers, creating an ecosystem that enables startups to directly engage with health system executives, driving solutions that address complex healthcare challenges. Ascension Ventures’ portfolio includes companies like Olive (an AI platform for healthcare administration), EBR Systems, and GetWellNetwork, reflecting its emphasis on technology that enhances clinical outcomes, patient experience, and operational efficiency. The firm typically invests between Series A and B rounds, with capital sizes ranging from $10 to $20 million per company, often seeking board seats or observer rights to guide their portfolio firms. The firm is distinguished by its close ties to 13 major health systems, which represent a network of over 580,000 healthcare professionals. This strategic positioning allows Ascension Ventures not only to provide funding but also to facilitate partnerships and scale innovations that improve healthcare delivery across the United States.

Asimov Ventures is an early-stage venture capital firm with offices in New York City and Palo Alto. The firm focuses on investing in cutting-edge technologies such as 3D printing, robotics, and advanced computing. Asimov Ventures seeks to partner with visionary entrepreneurs dedicated to transforming their industries through innovative solutions. Notable investments by Asimov Ventures include Particle3D, which specializes in 3D-printed bone implants, and Kadena, a blockchain technology company. The firm also invests in various other sectors, including healthcare, e-commerce, and augmented reality, reflecting their broad interest in transformative technologies​. Asimov Ventures typically participates in funding rounds with other notable investors, providing capital and strategic support to help startups scale and succeed. Their investment strategy emphasizes early-stage companies with strong intellectual property and commercial potential​.

Aspect Ventures, founded in 2014 by Jennifer Fonstad and Theresia Gouw, is a leading venture capital firm based in Palo Alto, California. The firm focuses on early-stage investments, primarily in Series A rounds, across various sectors including cybersecurity, fintech, digital health, and enterprise software. Notable investments include Gusto, a cloud-based HR management platform; Chime, a digital bank; and Exabeam, a cybersecurity company. Aspect Ventures has had several successful exits such as Forescout Technologies, Imperva, and Trulia.

Astanor Ventures, founded in 2017 by Eric Archambeau and George Coelho, is a Brussels-based venture capital firm specializing in sustainable agrifood technologies. The firm focuses on investing in early-stage, mission-driven companies that address significant social or environmental issues within the agrifood value chain. This includes sectors like regenerative agriculture, bioeconomy, and climate-positive solutions. Astanor recently closed its second venture fund at €360 million, bringing its total assets under management to €800 million. This fund will support innovative solutions aimed at transforming the global food system to be more sustainable and resilient​. The firm boasts an extensive network of entrepreneurs, experts, scientists, and policymakers, which helps identify and nurture groundbreaking technologies. Notable investments include companies that advance autonomous electric agricultural machinery, high-functioning proteins, and genomic sequencing for sustainable food production.

Aster Capital, established in 2000 and based in Paris, is a venture capital firm specializing in Climate Tech investments. The firm focuses on sectors such as energy, mobility, and industry, supporting startups at various stages of development. Aster Capital manages around €500 million in assets and operates globally with offices in Paris, San Francisco, and Tel Aviv. Key investments by Aster include companies like ekWateur, an energy supplier accelerating the energy transition; Betterway, a pioneer in employee mobility solutions; and Iceotope, specializing in liquid cooling technologies for data centers. These investments reflect Aster’s commitment to supporting innovative solutions that contribute to carbon neutrality. Aster recently raised €240 million to invest in energy transition and future mobility projects, underscoring their dedication to driving significant environmental impact through technology. The firm’s strategy involves not only financial investment but also providing extensive support through their "Business Hub" approach, which facilitates business opportunities and partnerships for their portfolio companies​.

Astera Institute is a venture capital fund dedicated to empowering visionary science and technology projects that can create transformative progress for human civilization. Founded by Jed McCaleb, the institute focuses on incubating high-leverage ideas at their earliest stages to effect systemic change through entrepreneurial experimentation. They invest in overlooked areas and support founders capable of initiating significant innovations, particularly in fields such as artificial general intelligence and open science​. Astera Capital, established in partnership with Flow Capital in 2020, operates as a hedge fund focused on fixed-income investments in Asia. Based in Hong Kong, Astera Capital aims to create value for its investors through strategic investments and an extensive network of industry relationships. The firm is committed to building a comprehensive alternative investment platform, leveraging the expertise of its experienced investment team to navigate complex financial markets​.

Astor Perkins is a New York-based venture capital firm focused exclusively on deep tech and human survival sectors. Established in 2020, the firm invests in cutting-edge technologies that address some of the most critical challenges humanity faces, both on Earth and in space. Its key areas of interest include space exploration, terraforming, plant-based foods, clean energy, longevity, AI, robotics, and quantum computing. Astor Perkins collaborates with global leaders aiming to build future cities, tackle climate change, and enhance human health and survival. The firm has been involved in notable investments such as D-Orbit, Bloom Diagnostics, and Lunar Station, backing companies at various stages of development. With its deep expertise, the fund prides itself on providing strategic, mission-critical advice that drives impactful innovations. Led by Scott Amyx, a recognized authority in emerging technologies, Astor Perkins is a major player in pushing the boundaries of deep tech, from AI to space technologies.

Asymmetric Financial is a venture capital firm that focuses on investing in early-stage companies within the fintech, software, and digital health sectors. Founded by Joe McCann in 2022, the firm operates with a unique approach to venture capital, combining deep expertise in technology and finance to support companies that are poised to disrupt traditional industries. Asymmetric Financial aims to identify and back innovative startups that leverage advanced technologies such as artificial intelligence, blockchain, and big data analytics to create new market opportunities. The firm’s investment strategy is centered on providing not only capital but also strategic guidance and operational support. Asymmetric Financial works closely with its portfolio companies to help them scale efficiently, offering assistance in areas such as financial planning, go-to-market strategies, and key performance indicator (KPI) development. This hands-on approach ensures that the startups in their portfolio are well-equipped to navigate the challenges of rapid growth and market competition. Asymmetric Financial is particularly interested in companies that have the potential to generate significant returns while also creating meaningful impact through their innovations. By focusing on sectors that are at the intersection of technology and finance, the firm aims to contribute to the modernization and transformation of the financial services industry.

Asymmetric Capital Partners (ACP) is a venture capital firm focused on backing B2B technology companies from Seed to Series C stages. Founded in 2020 by Rob Biederman, former co-CEO of Catalant Technologies, ACP manages an oversubscribed debut fund of $105 million. The firm targets disruptive businesses in areas like healthcare IT, fintech, marketplaces, and next-gen software, especially those transforming legacy industries and capitalizing on digital innovation. ACP is known for its hands-on approach, leveraging a team of founders and former operators who work closely with startups on strategic growth areas such as hiring, go-to-market strategies, and financial planning. They typically invest between $2M to $10M, with the flexibility to co-invest in larger deals alongside top firms like Andreessen Horowitz and Sequoia Capital. Some notable investments include Firstbase, a remote work platform backed by Andreessen Horowitz, and Clearco, a fintech company. The firm prides itself on being deeply involved with its portfolio companies, providing both operational support and access to a vast network of advisors and industry experts.

Asymmetry Ventures, based in San Francisco, is a prominent early-stage venture capital firm founded by Rob Ness. The firm focuses on investing in transformative startups that have the potential to create significant impact. They have a diverse portfolio of over 280 investments, including notable companies like BillionToOne, Foresight Mental Health, Mast Reforestation (formerly DroneSeed), and Orbit Fab. Asymmetry Ventures is known for their commitment to supporting defensible businesses, particularly in sectors such as artificial intelligence, biotechnology, and aerospace. They typically make initial investments in the range of $2 million and have been involved in notable funding rounds such as Orbit Fab's $10 million raise, which also saw participation from major aerospace players like Northrop Grumman and Lockheed Martin. The firm prides itself on identifying and backing visionary founders and innovative business models, with a strong emphasis on early-stage investments that leverage technology to create natural barriers to entry and generate recurring revenue streams. They also prioritize investments that address significant market needs with scalable solutions. For startups looking to partner with Asymmetry Ventures, demonstrating a strong leadership team and a clear path to market dominance are crucial. The firm's deep network and extensive industry experience provide valuable support and guidance to their portfolio companies, enhancing their potential for growth and success.

AT Inc, now known as Amazon Catalytic Capital, is Amazon’s venture capital initiative with an initial commitment of $150 million aimed at supporting underrepresented founders. The fund invests in venture capital funds, accelerators, incubators, and venture studios that prioritize startups led by Black, Latino, Indigenous, women, and LGBTQIA+ entrepreneurs. This initiative not only provides financial backing but also offers mentorship from Amazon executives and access to resources that can aid in business and technical strategy. Key investments include Collide Capital, Elevate Future Fund, Share Ventures, and Techstars Rising Stars Fund. These funds focus on diverse founders working in areas such as clean energy, fintech, health tech, and consumer goods. Amazon’s goal is to foster inclusion and innovation, ultimately driving economic growth and creating generational wealth for historically underserved communities.

At One Ventures is a venture capital firm founded in 2020 by Tom Chi, a founding member of Google X. The firm is dedicated to investing in early-stage startups that are developing disruptive deep tech solutions aimed at making humanity a net positive to nature. With a strong focus on climate tech, At One Ventures has established itself as a significant player in the industry. The firm recently closed its second fund at $375 million, indicating strong investor confidence and a robust commitment to supporting climate-positive innovations. This fund follows their initial $150 million fund and aims to support startups that can dramatically reduce environmental footprints while upending established industrial economics. At One Ventures' investment portfolio includes companies across various sectors such as renewable energy, sustainable agriculture, and advanced materials. Notable investments include Noon Energy, which focuses on long-duration energy storage, and MightyFly, which is developing hybrid electric drone delivery systems. The firm's approach is hands-on, providing strategic guidance in talent acquisition, operations, marketing, IP strategy, and manufacturing. The team at At One Ventures consists of experienced professionals with backgrounds in physical sciences, engineering, manufacturing, and finance, ensuring a deep understanding of the technologies and markets they invest in. They operate globally, with a presence in San Francisco and London, and continue to seek partnerships with entrepreneurs, scientists, and investors who share their vision for a sustainable future.

Atelier Ventures, founded by Li Jin, is an early-stage venture capital firm focused on the "Passion Economy," a concept that promotes enabling individuals to monetize their unique talents, creativity, and knowledge. This shift reflects the growing trend of people transitioning away from traditional employment toward independent work that aligns with their personal passions. Li Jin, who previously worked at Andreessen Horowitz, launched Atelier Ventures to fund companies that help democratize access to entrepreneurship. The firm’s investment thesis revolves around empowering creators by providing them with the tools, platforms, and resources to turn their individuality into income. Atelier Ventures supports startups building solutions that reduce the barriers to entry for entrepreneurship, including fintech platforms, SaaS tools, and educational services. These platforms facilitate the creation, distribution, and monetization of content, whether through podcasting, e-commerce, or other creative fields. Atelier Ventures focuses on businesses that promote independence while fostering community and collaboration among creators. Atelier’s portfolio includes companies that are reshaping the future of work by making it easier for creators to build and scale businesses. The firm envisions a future where creators, freelancers, and solopreneurs can collaborate in trusted networks and thrive in the digital age. This vision aligns with Li Jin's mission to support founders who challenge the status quo and create new, fulfilling work opportunities in the evolving digital landscape.

Atento Capital is a Tulsa-based venture capital firm founded with the mission of supporting early-stage tech startups, particularly those in underinvested communities. The firm was launched with backing from the George Kaiser Family Foundation, focusing on generating both market returns and social impact by funding innovative companies in the Heartland region of the U.S. Atento primarily invests in seed and early-stage companies, with check sizes ranging from $250,000 to $3 million. They are committed to fostering diversity in entrepreneurship, directing nearly half of their capital to underrepresented founders, including women and founders of color. Notable portfolio companies include RobbieAI, a platform using computer vision to prevent patient injuries, and PatchRx, a health tech solution aimed at improving medication adherence​. Beyond funding, Atento provides hands-on support to startups by offering mentorship, business development guidance, and access to local talent via partnerships with organizations like inTulsa. Their approach is deeply rooted in building long-term success for founders who have traditionally been overlooked by the broader venture capital ecosystem.

Atinum Investment, the venture capital arm of Atinum Partners, is a prominent South Korean investment firm with over $450 million in assets under management. The firm focuses on diverse sectors such as deep tech, artificial intelligence, blockchain, advanced robotics, bio-healthcare, and IT components. They actively invest in early-stage to growth-stage startups with significant global market potential. Notable portfolio companies include CryptoQuant, Allganize, and Klook. Atinum Investment has a global reach, particularly focusing on Southeast Asia, with investments in companies like InstaReM and Fast Five, a South Korean co-working space startup. The team at Atinum Investment includes key figures such as Wan Gee Cho, who specializes in deep tech and SaaS investments, and Peter Na, the Regional Head for Southeast Asia, focusing on investments in the region from the Singapore office. Atinum is committed to providing more than just capital by offering strategic guidance and opening doors to potential customers and partners, ensuring the growth and success of their portfolio companies.

Atlantic Bridge, founded in 2004, is a global growth equity technology firm that focuses on investing in deep technology companies across Europe, the UK, and the US. With over €1 billion in assets under management, the firm has a portfolio of 70 companies and has created over 5,000 jobs. Atlantic Bridge is known for its cross-border value-add strategy, helping portfolio companies expand internationally through its offices in Dublin, London, Munich, Paris, and Palo Alto. The firm's portfolio includes notable companies such as SOC Prime, which specializes in enterprise threat detection and response, and Elisity, which combines Zero Trust Network Access with an AI-enabled Software Defined Perimeter. Other significant investments include Siren, an investigative intelligence platform, and Aizon, which optimizes pharmaceutical manufacturing processes using real-time data and predictive models. Atlantic Bridge has achieved successful exits with companies like Navitas Semiconductor, which recently debuted its GaN Power ICs on Nasdaq, and Mitiga, a provider of hybrid managed services for incident response and readiness. The firm is led by experienced industry professionals, including Managing Partners Elaine Coughlan, Brian Long, and Kevin Dillon, who bring extensive expertise in scaling technology companies and executing successful IPOs and M&As.

FoodLabs, founded in 2015 and based in Berlin, Germany, is a prominent venture capital firm dedicated to investing in innovative startups within the food, health, and sustainability sectors. The firm supports companies aiming to revolutionize how we produce, consume, and think about food, with a mission to create sustainable and healthy solutions for the future. FoodLabs has made a significant impact with its diverse portfolio, which includes companies like ChefCoco, a personalized weekly menu service, and Van Heron Labs, which focuses on biotechnology. The firm has been an early investor in some of the most influential European FoodTech startups, such as Infarm, Meatable, Mushlabs, and Sanity Group. These investments span across various stages, from pre-seed to series B and beyond, demonstrating FoodLabs' commitment to nurturing startups through their growth journey. The team at FoodLabs, led by founder Christophe Maire and managing director Patrick Noller, combines deep industry expertise with a strong network to provide strategic support and resources to their portfolio companies. They are particularly focused on sectors like synthetic biology, climate resilience, and health, aiming to address some of the world's most pressing challenges.

Atlantic Labs, based in Berlin, is a prominent early-stage venture capital firm that supports mission-driven founders across Europe. Founded in 2013, the firm has a focus on investing in transformative technology sectors such as climate tech, digital health, future of work, AI and data, industrial automation, mobility and logistics, fintech, and proptech. Atlantic Labs typically invests at the pre-seed stage, with investment sizes ranging from €25,000 to €5 million or more. They have backed over 215 companies, including notable names like SoundCloud, GetYourGuide, Clue, Vimcar, and Cazoo. The firm emphasizes a hands-on approach, providing not only capital but also strategic guidance and access to a robust network of industry experts to help their portfolio companies grow and succeed. The firm's portfolio reflects its diverse focus areas, supporting companies that aim to redefine various industries through innovative solutions. Examples include digital health companies like Clue, AI and data startups such as Mobius Labs, and mobility ventures like GetYourGuide and Cazoo. Atlantic Labs is led by a team of experienced investors and operators who are committed to supporting entrepreneurs throughout their entire journey. This commitment to fostering innovation and growth has established Atlantic Labs as a key player in the European venture capital landscape.

Atlas Venture is a leading biotech venture capital firm focused on creating and building innovative life science companies. With over 30 years of experience, they have incubated over 70 startups and taken 40 companies public, including Intellia Therapeutics, Kymera Therapeutics, and Generation Bio. Atlas specializes in drug discovery and development, emphasizing areas like gene editing, oncology, and immunotherapy. Headquartered in Cambridge, Massachusetts, Atlas primarily targets U.S.-based startups but maintains a global vision, partnering with top scientific minds. They invest early, often leading seed and Series A rounds, with typical check sizes ranging from $5M to $20M. Atlas's approach is hands-on, actively incubating new ventures and co-founding companies with a strong operational focus. Key figures include Jean-François Formela, who has been instrumental in several high-profile exits and IPOs, and focuses on cutting-edge drug discovery technologies. Founders approaching Atlas should focus on breakthrough science with clear therapeutic applications, as the firm seeks to translate groundbreaking research into life-changing medicines.

Atlas Venture is a leading venture capital firm specializing in early-stage investments in biotechnology and life sciences. Founded in 1980 and based in Cambridge, Massachusetts, Atlas Venture has built a robust portfolio by focusing on groundbreaking biotech innovations. The firm has raised multiple funds, including their most recent Fund XIII at $450 million, which emphasizes their commitment to fueling biotech startups from seed stage through to successful exits​. Notable investments in their portfolio include companies like Intellia Therapeutics, Kymera Therapeutics, and Ikena Oncology. These investments highlight Atlas Venture's dedication to developing therapies that address significant unmet medical needs, particularly in oncology and genetic disorders. Intellia Therapeutics, for instance, is renowned for its gene-editing technologies, while Kymera Therapeutics focuses on protein degradation to treat diseases. Atlas Venture has achieved numerous successful exits, such as the acquisitions of IFM Therapeutics by Bristol-Myers Squibb and Novartis, and the IPO of Generation Bio. These exits underscore the firm’s strategic capability in identifying and nurturing high-potential biotech startups to maturity. The firm is led by a team of experienced partners, including Jean-Francois Formela, Jason Rhodes, and David Grayzel, who bring a wealth of expertise in venture capital and life sciences. This team collaborates closely with entrepreneurs to provide not just capital but also strategic guidance and operational support, leveraging their extensive network within the biotech industry. For startups aiming to partner with Atlas Venture, it is crucial to present innovative solutions with strong scientific foundations and clear pathways to address significant medical challenges. The firm values startups that demonstrate potential for substantial clinical impact and scalability within the healthcare sector.

AtmosClear Investments is a Lausanne-based venture capital firm dedicated to accelerating the clean-tech revolution by investing in disruptive technologies that drive sustainability. Established in 2001, AtmosClear focuses on sectors like renewable energy, water purification, sustainable agriculture, and smart city infrastructure. Their diverse portfolio includes companies working on innovative solutions such as large-scale solar and wind energy projects, energy storage, recycling systems, and biofuels, with investments across Europe, particularly the UK and Switzerland. One of their notable ventures is Close the Loop, a recycling company specializing in repurposing ink cartridges, and they have also managed major solar installations in the UK, totaling over 30 MW. The firm’s mission is to generate both financial returns and positive environmental impact, emphasizing the reduction of harmful pollutants like microplastics and greenhouse gases. They support companies at various stages, from early startups to more mature businesses in need of growth capital​. AtmosClear’s team is led by experienced professionals with decades of expertise in finance and private markets. Founder Henry Sykes and his team leverage their deep knowledge to identify opportunities that align with their sustainability ethos. The firm’s global reach is underscored by investments in multiple continents, and they continue to seek out promising clean-tech entrepreneurs who share their vision of a more sustainable future. With a strong emphasis on long-term ecological benefits, AtmosClear is setting a new standard for responsible, impactful investing in the clean-tech space.

Atomico, founded in 2006 by Skype co-founder Niklas Zennström, is a leading venture capital firm based in London, with additional offices in Paris, Berlin, and Stockholm. The firm focuses on Series A and beyond investments in disruptive technology companies globally. Atomico's notable investments include Klarna, Truecaller, Lime, Hinge Health, and Rovio, which highlight their strong presence in fintech, healthcare, consumer tech, and gaming sectors. Atomico's investment strategy centers around partnering with mission-driven European founders, providing them with not just capital but also extensive operational support through their Growth Acceleration Team. This team assists with scaling operations, strategic planning, and navigating complex market dynamics. Their typical investment range is from $10 million to $50 million, and they often lead rounds, ensuring significant influence in their portfolio companies' trajectories. The firm is known for its diverse team and deep industry expertise. Key figures include Niklas Zennström, CEO and Partner; Chris Barnes, COO; and Thomas Wehmeier, Partner and Head of Insights, all based in London. This diverse leadership team brings a wealth of experience from various sectors, enhancing their ability to support and scale innovative startups. For startups looking to engage with Atomico, it's crucial to showcase innovative solutions with a potential for significant market impact. The firm is particularly interested in technology-driven companies that can leverage shifts in consumer behavior and technological advancements.

Atooro Fund is a venture capital firm based in Tel Aviv, Israel, established in 2016. It focuses on investing in seed, early-stage, growth-stage, and later-stage companies. The fund primarily targets sectors such as information technology, cybersecurity, food technology, agricultural technology, artificial intelligence, and machine learning. The fund supports innovative entrepreneurs and helps them build global companies. Atooro Fund’s investment strategy involves backing startups that bring significant advancements in their respective fields. Notable investments include Beewise, which specializes in autonomous beehive technology, QuantHealth, and Wisor AI, which operates in the AI and machine learning domains. The firm is led by Jacob Engel, who serves as the Chairman, and Yonatan Brender, the General Managing Partner. Engel is known for his extensive background in various industries, including mining and real estate, while Brender brings a wealth of experience in venture capital and technology investments. Atooro Fund aims to foster innovation and growth by providing not only financial support but also strategic guidance and resources to its portfolio companies, ensuring they can navigate challenges and achieve sustainable growth.

ATP Fund, established in 2014 and headquartered in Austin, Texas, is an early-stage venture capital firm that focuses on deep tech investments aimed at advancing human conditions through scientific innovation. The firm specializes in sectors such as artificial intelligence (AI), biotechnology, cleantech, cybersecurity, enterprise software, healthcare, and robotics. ATP Fund is known for its strategic investments in startups that are tackling some of the most challenging and impactful problems of our time. ATP Fund adopts a contrarian and hands-on approach, often partnering with scientific entrepreneurs at the earliest stages of their ventures, sometimes even at the formation stage via their Proto.n initiative. This strategy reflects their commitment to long-term partnerships and their belief in the transformative potential of cutting-edge technologies. The fund's portfolio includes a variety of high-impact companies like Diligent Robotics, which focuses on healthcare robotics, and Infleqtion, a firm that specializes in quantum technology. These investments highlight ATP Fund's dedication to supporting ventures that have the potential to make significant advancements in their respective fields. ATP Fund collaborates with a wide network of co-investors, including notable names like Texas Venture Labs and Osage University Partners. The firm has also seen successful exits, further establishing its reputation as a key player in the deep tech investment landscape.

ATX Seed Ventures, now operating as ATX Venture Partners, is an Austin, Texas-based early-stage venture capital firm founded in 2014 by Brad Bentz, Danielle Weiss Allen, and Chris Shonk. The firm manages more than $60 million in assets, including a $32 million second fund raised in 2019, and focuses on leading seed and Series A investments in disruptive B2B software, APIs, applications, frontier tech, and marketplaces. It leads rounds with checks averaging $2.5 million, up to $5 million per investment. ATX has invested in 26-plus companies and established itself as one of the most active early-stage funds in the Texas technology ecosystem. Notable portfolio companies include Alert Media, SourceDay, GoCo, LIFT Aircraft, Pensa Systems, QuotaPath, Slingshot Aerospace, and monoDrive — representing the breadth of its coverage across supply chain, fintech, insurtech, and frontier tech sectors. Limited partners include successful entrepreneurs, executives, institutions, and family offices. The firm rebranded from ATX Seed Ventures to ATX Venture Partners in 2019 to reflect expanded scope beyond strictly seed-stage investing. Its geographic concentration in Austin — one of the fastest-growing technology hubs in the United States — gives the team deep local relationships and access to deal flow that coastal funds often miss. The founding partners bring complementary operational and investing backgrounds, enabling hands-on support for portfolio companies navigating product development, go-to-market, and early scaling challenges.

Atypical Ventures is a venture capital firm founded by Ruby Lu in 2019, focusing on early-stage technology companies. The firm has a global presence with offices in the United States and China, investing in sectors such as high-tech, environment tech, and enterprise applications. Atypical Ventures has a strong emphasis on supporting engineers who are solving foundational challenges in nascent markets. The firm’s portfolio includes companies like Buddy, an insurtech startup, and Norm Ai, which focuses on enterprise applications. Atypical tends to make seed and early-stage investments, with notable participation in rounds alongside co-investors like Coatue and DCVC. The firm is known for its hands-on approach, helping founders develop disruptive solutions that are shaping the future. Led by Ruby Lu and a small team of experienced professionals, Atypical Ventures is carving a niche in backing innovative tech solutions across the globe.